ADMET Profiling for SARS-CoV-2

A number of computational methods have been used in various aspects of drug discovery and development. In recent decades, in silico ADMET (absorption, distribution, degeneration, excretion, and toxicity) modeling as a rational drug design tool has received extensive attention from pharmaceutical scientists The low-cost and high-throughput characteristics of these models allow for a more simplified drug development process in which the drug accessibility of compounds can be predicted, and the identification of hits and structural optimization. ADMET Profiling for SARS-CoV-2 can be guided. Creative Biostructure is a trusted partner in the development of antiviral drugs for coronavirus infection, and we can support ADMET modeling and profiling.